Germany · Funded startup

Who invested in Life Molecular Imaging

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 15 Nov 2026

$2.2Mraised across 1 round since 2025, from 1 source

Latest round
Grant, $2.2MMay 2025
Investors
0
See who backed them

The rounds

  1. May 2025
    Grant$2.2M

    No investor was named in the report.

    Source recorded

Founders and team

From Life Molecular Imaging's own website: 16 on the team.

  • Dorothy BarrSenior Vice President, Manufacturing and Technical Operations
  • Joann NestorSenior Vice President, Legal Affairs
  • Neil HollandVice President of Business Insights & Operations
  • Mary Anne HeinoExecutive Chairperson and Interim CEO
  • Cheryl BallChief Strategy Officer and Head of Corporate Development
  • Amanda MorganChief Commercial Officer
  • Jamie SpaethChief People Officer
  • Kim BrownChief Accounting Officer
  • Lee Anne HoweChief Information Officer
  • Robert J. Marshall Jr.Chief Financial Officer
  • Gary J. PrudenDirector
  • Heinz MäusliDirector
  • Julie EastlandDirector
  • Julie McHughDirector
  • Minnie Baylor-HenryDirector
  • Samuel LenoDirector

Quick answers about Life Molecular Imaging

How much has Life Molecular Imaging raised?

Life Molecular Imaging has raised $2.2M across 1 round since 2025.

When did Life Molecular Imaging last raise?

Life Molecular Imaging's most recent round was a Grant of $2.2M in May 2025.

What was Life Molecular Imaging's biggest round?

Its most recent round, $2.2M in May 2025, is also its largest on record.

What stage is Life Molecular Imaging at?

Life Molecular Imaging's latest named round is a Grant, in May 2025.

Where is Life Molecular Imaging based?

Life Molecular Imaging is based in Germany.

Companies like Life Molecular Imaging

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.